PMC:7443692 / 2742-3026 JSONTXT

{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T12","span":{"begin":196,"end":203},"obj":"Chemical"},{"id":"T13","span":{"begin":205,"end":212},"obj":"Chemical"},{"id":"T14","span":{"begin":218,"end":226},"obj":"Chemical"}],"attributes":[{"id":"A12","pred":"chebi_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/CHEBI_87631"},{"id":"A13","pred":"chebi_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_28304"},{"id":"A14","pred":"chebi_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/CHEBI_35341"}],"text":"2020; Zhou et al., 2020). Given the rapid appearance and spread of this virus, there is no current validated vaccine or SARS-CoV-2-specific targeting therapy that is clinically approved, although statins, heparin, and steroids look promising for lowering fatality rates, and antiviral"}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T20","span":{"begin":120,"end":130},"obj":"Species"}],"attributes":[{"id":"A20","pred":"ncbi_taxonomy_id","subj":"T20","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"2020; Zhou et al., 2020). Given the rapid appearance and spread of this virus, there is no current validated vaccine or SARS-CoV-2-specific targeting therapy that is clinically approved, although statins, heparin, and steroids look promising for lowering fatality rates, and antiviral"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T13","span":{"begin":120,"end":130},"obj":"Disease"}],"attributes":[{"id":"A13","pred":"mondo_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"2020; Zhou et al., 2020). Given the rapid appearance and spread of this virus, there is no current validated vaccine or SARS-CoV-2-specific targeting therapy that is clinically approved, although statins, heparin, and steroids look promising for lowering fatality rates, and antiviral"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T12","span":{"begin":72,"end":77},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"2020; Zhou et al., 2020). Given the rapid appearance and spread of this virus, there is no current validated vaccine or SARS-CoV-2-specific targeting therapy that is clinically approved, although statins, heparin, and steroids look promising for lowering fatality rates, and antiviral"}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T14","span":{"begin":205,"end":212},"obj":"Body_part"}],"attributes":[{"id":"A14","pred":"fma_id","subj":"T14","obj":"http://purl.org/sig/ont/fma/fma82839"}],"text":"2020; Zhou et al., 2020). Given the rapid appearance and spread of this virus, there is no current validated vaccine or SARS-CoV-2-specific targeting therapy that is clinically approved, although statins, heparin, and steroids look promising for lowering fatality rates, and antiviral"}

{"project":"2_test","denotations":[{"id":"32841605-32197085-19659459","span":{"begin":0,"end":4},"obj":"32197085"},{"id":"32841605-32015507-19659460","span":{"begin":19,"end":23},"obj":"32015507"}],"text":"2020; Zhou et al., 2020). Given the rapid appearance and spread of this virus, there is no current validated vaccine or SARS-CoV-2-specific targeting therapy that is clinically approved, although statins, heparin, and steroids look promising for lowering fatality rates, and antiviral"}